Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5. - Wikidata - awgldk - TriplyDB

Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5.

Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5.

http://www.wikidata.org/entity/Q33598794

about

Integrating the puzzle pieces: the current atomistic picture of phospholipid-G protein coupled receptor interactions 4-Methoxy-N-[2-(trifluoromethyl)biphenyl-4-ylcarbamoyl]nicotinamide: A Potent and Selective Agonist of S1P1.Optimization of a Potent, Orally Active S1P1 Agonist Containing a Quinolinone Core.Predictability of peripheral lymphocyte reduction of novel S1P1 agonists by in vitro GPCR signaling profile.Modulators of the Sphingosine 1-phosphate receptor 1.Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.Selective arylation and vinylation at the α position of vinylarenes.

P2860

Q26828893-A9512FEE-67CB-436C-AC68-5B12EFE5EF00 Q33598692-A084A942-15F8-4CA4-AAB7-CBB23BF54C29 Q33630400-D606F5F3-F6E4-4F34-8FED-60F902EA9F1B Q34728125-7E7A12A3-B186-45C4-A98C-8D54C59E698D Q38152543-B7B4C19E-95A8-432A-B35D-1FB511B12B58 Q38915115-37C17759-6AAC-41D1-A887-8CF7E61A4EE3 Q51274379-30536F8D-C64C-411F-8AA3-857BF1BCD8D5

P2860

Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5.

http://www.wikidata.org/entity/Q33598794

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5.

@ast

Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5.

@en

type

label

Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5.

@ast

Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5.

@en

prefLabel

Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5.

@ast

Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5.

@en

P1433

Q33598794-28D259BD-3BA7-467A-BAF7-BA30B2B03ADB

P1476

Q33598794-EB786EC3-C979-4650-A5FC-916F23A89FFA

P2093

Q33598794-01F88795-A2BB-4D17-BBAC-2187C3119BC1

Q33598794-07DFCC18-1A7D-4858-8C5A-4ADF78908046

Q33598794-08DF3ADF-9063-44CE-A433-1F8CF872021A

Q33598794-16BE63B2-35EC-4A87-AF22-19B53EB76084

Q33598794-18C8B0C2-904D-4FB8-8500-8E35B5D813B0

Q33598794-2B52522F-5603-41F0-991A-13CDBFAE3E18

Q33598794-2CB8FDBC-6B0F-4AC1-8C9B-D709BDB6C6CF

Q33598794-42C22ABC-7B26-48F6-8F53-7B2394DBB8B5

Q33598794-4ED99F45-DC09-4B3D-9217-6358C859AFA1

Q33598794-51E1709E-C5D7-4B81-9B17-C732D26DFBEC

P2860

Q33598794-1428A43D-62E6-4430-B4F8-7237423DA064

Q33598794-220E8010-83CF-4B8D-9C50-C5F7CAD58363

Q33598794-220EAE17-7E51-4EA7-93D7-C8E074F16B06

Q33598794-2DE6A5C5-8FFD-4C93-ACB6-D890FE0E849E

Q33598794-6382A926-B832-4917-ACE9-F1D107367105

Q33598794-685E39A9-61CD-468A-A209-2046CC98DE96

Q33598794-6A77825B-D405-4A52-B6C8-E83284C3EFC0

Q33598794-6B0869D5-6B63-47EB-9CE1-2262D6DF0563

Q33598794-86435AA0-12CF-41DE-8359-6735BC53306D

Q33598794-89766DF2-9357-42D9-9461-D2DC33DFAC4B

P304

Q33598794-04591AFD-B49C-46C6-97F9-B968631E8FA5

P31

Q33598794-FF00FDFB-4B56-4CAD-A8C0-08A493640F94

P356

Q33598794-4DFEABD9-F088-452B-8055-8F78262D6DAF

P433

Q33598794-8F0D5E66-DBAC-4A3A-859D-ECA62EAFD980

P478

Q33598794-62893F80-D6F7-44CA-9C74-171B4124E080

P50

Q33598794-BA49DAB4-3B82-4201-90B1-29CB1CBF050B

Q33598794-DF4FCF8A-DF3B-40AD-BE82-83002D959F61

P577

Q33598794-99E0FE3D-6889-4843-828B-D9B896643C20

P5875

Q33598794-C3A7BB78-41EA-4DC7-A8F8-BA941FB08C00

P698

Q33598794-38B980F9-5BFC-4C88-8BE0-FD48A0A3D9FE

P932

Q33598794-057B1752-2C63-4906-BFA3-F1E9EFB2AEC5

P356

P1433

ACS Medicinal Chemistry Letters

P1476

Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P1 and S1P5.

@en

P2093

Alex Pickrell

http://www.w3.org/2001/XMLSchema#string

Andrea Itano

http://www.w3.org/2001/XMLSchema#string

Anu Gore

http://www.w3.org/2001/XMLSchema#string

Dalia Rivenzon-Segal

http://www.w3.org/2001/XMLSchema#string

Han Xu

http://www.w3.org/2001/XMLSchema#string

Heather Arnett

http://www.w3.org/2001/XMLSchema#string

Hugo M Vargas

http://www.w3.org/2001/XMLSchema#string

Janet Buys

http://www.w3.org/2001/XMLSchema#string

Jerry Siu

http://www.w3.org/2001/XMLSchema#string

Kristine Muller

http://www.w3.org/2001/XMLSchema#string

P2860

Principles of bioactive lipid signalling: lessons from sphingolipids

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

Discovery of a Potent, S1P3-Sparing Benzothiazole Agonist of Sphingosine-1-Phosphate Receptor 1 (S1P1)

A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists.

Physiochemical drug properties associated with in vivo toxicological outcomes.

Sphingosine 1-phosphate receptor signaling.

Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules

Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.

P304

107-112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ML100306H

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer E. Golden

P577

2010-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231712144

http://www.w3.org/2001/XMLSchema#string

P698

24900288

http://www.w3.org/2001/XMLSchema#string

P932

4018127

http://www.w3.org/2001/XMLSchema#string